Clinicopathological significance of B-cell-specific Moloney murine leukemia virus insertion site 1 expression in gastric carcinoma and its precancerous lesion

Table 3 Correlation between ki-67 and Bcl-2 expression and clinicopathological features of GC (Fisher's exact test)

Group	n	ki-67 expression	χ2	P	Bcl-2 expression	χ2	P
		+-+++(%)			+-+++(%)
Gender			0.584	0.445		0.558	0.455
Male	116	98 (84.5)			68 (58.6)
Female	46	41 (89.1)			24 (52.2)
Age (yr)			0.004	0.950		0.206	0.650
≤ 60	82	71 (86.6)			48 (58.5)
> 60	80	69 (86.3)			44 (55.0)
Clinicopathological classification				0.080		1.464	0.226
EGC	30	29 (96.7)			20 (66.7)
AGC	132	111 (84.1)			72 (54.5)
Gross classification
EGC				0.367			1.000
I + IIc	19	19 (100.0)			13 (68.4)
III	11	10 (90.9)			7 (63.6)
AGC			13.380	< 0.001		2.632	0.105
BorI + II	25	15 (60.0)			10 (40.0)
BorIII + IV	107	96 (89.7)			62 (57.9)
WHO’s histological classification			4.262	0.601		8.640	0.169
PA	4	4 (100.0)			3 (75.0)
WDA	12	11 (91.7)			8 (66.7)
MDA	50	45 (90.0)		1.000a	31(62.0)		1.000a
PDA	75	63 (84.0)		0.684b	35 (46.7)		0.229b
SRC	10	8 (80.0)			6 (60.0)
MA	9	8 (88.9)			8 (88.9)
UA	2	1 (50.0)			1 (50.0)
Lauren's classification			2.146	0.143		5.552	0.018
Intestinal type	75	68 (90.7)			50 (65.8)
Diffuse type	87	72 (82.8)			42 (48.8)
Lymph node metastasis			0.021	0.885		0.045	0.832
No	98	85 (86.7)			55 (56.1)
Yes	64	55 (85.9)			37 (57.8)

Fisher's exact test,

^aP = 1.000, 1.000 vs PDA;

^bP = 0.684, 0.229 vs PDA.